Details of the Drug Formulations

General Information of Drug (ID: DM6QOVN)

Drug Name
HKI-272 Drug Info
Synonyms Neratinib (ERBB2 inhibitor)
Indication
Disease Entry ICD 11 Status REF
Breast cancer 2C60-2C65 Phase 3 [1] , [2]
Therapeutic Class
Anticancer Agents
Cross-matching ID
PubChem CID
9915743
ChEBI ID
CHEBI:61397
CAS Number
698387-09-6
TTD ID
D0Q9CY
INTEDE ID
DR1887
ACDINA ID
D00463

Full List of Drug Formulations Containing This Drug

Neratinib 40 mg tablet
Company Formulation ID FDA Description
Puma Biotechnology F15158 Magnesium stearate; Mannitol; Ferric oxide red; Talc; Titanium dioxide; Water; Crospovidone; Povidone; Silicon dioxide; Microcrystalline cellulose; Polyethylene glycol, unspecified; Polyvinyl alcohol, unspecified
------------------------------------------------------------------------------------
Neratinib Maleate 40 mg tablet
Company Formulation ID FDA Description
Puma Biotechnology F23351 Colloidal Silicon Dioxide; Mannitol; Microcrystalline Cellulose; Crospovidone; Povidone; Magnesium Stearate; Purified Water; Polyvinyl Alcohol; Titanium Dioxide; Polyethylene Glycol; Talc; Iron Oxide Red
------------------------------------------------------------------------------------

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800021154)
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)